Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot study.

MLA

Kobayashi, Eisuke, et al. “Lipid-Functionalized Dextran Nanosystems to Overcome Multidrug Resistance in Cancer: A Pilot Study.” Clinical Orthopaedics and Related Research, vol. 471, no. 3, Mar. 2013, pp. 915–25. EBSCOhost, https://doi.org/10.1007/s11999-012-2610-2.

APA

Kobayashi, E., Iyer, A. K., Hornicek, F. J., Amiji, M. M., & Duan, Z. (2013). Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot study. Clinical Orthopaedics and Related Research, 471(3), 915–925. https://doi.org/10.1007/s11999-012-2610-2

Chicago

Kobayashi, Eisuke, Arun K Iyer, Francis J Hornicek, Mansoor M Amiji, and Zhenfeng Duan. 2013. “Lipid-Functionalized Dextran Nanosystems to Overcome Multidrug Resistance in Cancer: A Pilot Study.” Clinical Orthopaedics and Related Research 471 (3): 915–25. doi:10.1007/s11999-012-2610-2.